These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 21186532)

  • 1. [The analysis of clinical character in different age patients suffered from A-H1N1].
    Zhao Y; Zhang YH; Liang LC; Zhang X; Zhang Q; Zhu YK; Liu Y; Feng X; Ma DM; Tan YF; Wu H; Yan HP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):218-20. PubMed ID: 21186532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of 96 cases with novel H1N1 influenza A].
    Wang YF; Guo JC; Lou GQ; Xun YH; Yu XL; Shi WZ; Shi JP; Yu JH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):212-4. PubMed ID: 21186530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections.
    Papenburg J; Baz M; Hamelin MÈ; Rhéaume C; Carbonneau J; Ouakki M; Rouleau I; Hardy I; Skowronski D; Roger M; Charest H; De Serres G; Boivin G
    Clin Infect Dis; 2010 Nov; 51(9):1033-41. PubMed ID: 20887206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
    Bruj J; Skocil V; Farník J; Hronovský F; Síp J
    Cesk Epidemiol Mikrobiol Imunol; 1981 Sep; 30(5):287-93. PubMed ID: 6456837
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 6. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza in China in 1977: recurrence of influenzavirus A subtype H1N1.
    Kung HC; Jen KF; Yuan WC; Tien SF; Chu CM
    Bull World Health Organ; 1978; 56(6):913-8. PubMed ID: 310732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of the antibody status to current influenza strains in the Norwegian population. 2: Antibodies to the A/USSR/90/77 (H1N1) virus in various age groups after the second epidemic wave.
    Haaheim LR
    NIPH Ann; 1980 May; 3(1):49-56. PubMed ID: 7454125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monovalent influenza A(H1N1) vaccine, 1986-1987.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Aug; 35(32):517-21. PubMed ID: 3090424
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response to A/Taiwan/86 (H1N1) virus in young adults receiving supplemental monovalent A/Taiwan/86 influenza vaccine following trivalent influenza vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Jan; 35(53):818-9. PubMed ID: 3099156
    [No Abstract]   [Full Text] [Related]  

  • 11. Estimating pathogen-specific asymptomatic ratios.
    Wang TE; Lin CY; King CC; Lee WC
    Epidemiology; 2010 Sep; 21(5):726-8. PubMed ID: 20585253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic analysis of recent influenza A(H1N1) viruses.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1983 Oct; 32(41):534-5. PubMed ID: 6431244
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic variation of recent influenza A(H1N1) viruses.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Aug; 35(32):510-2. PubMed ID: 3090423
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunology. Flu antibodies stir new hope for treatment, vaccine.
    Leslie M
    Science; 2009 Feb; 323(5918):1160. PubMed ID: 19251602
    [No Abstract]   [Full Text] [Related]  

  • 17. Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Jul; 33(ACS-7):1-38. PubMed ID: 17663034
    [No Abstract]   [Full Text] [Related]  

  • 18. Responses to 2009 H1N1 vaccine in children 3 to 17 years of age.
    Arguedas A; Soley C; Lindert K
    N Engl J Med; 2010 Jan; 362(4):370-2. PubMed ID: 20042746
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza A (H1N1) pandemic: preparedness and clinical management.
    Khanna M; Gupta N
    Indian J Exp Biol; 2009 Nov; 47(11):929-32. PubMed ID: 20099469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.